Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Axonics Inc (NQ: AXNX ) 67.72 -0.28 (-0.41%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 494,860 Open 68.17 Bid (Size) 67.21 (1) Ask (Size) 68.19 (1) Prev. Close 68.00 Today's Range 67.60 - 68.28 52wk Range 48.30 - 69.68 Shares Outstanding 46,134,513 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia May 16, 2024 From Axonics, Inc. Via Business Wire AXNX Stock Earnings: Axonics Misses EPS, Beats Revenue for Q1 2024 April 30, 2024 AXNX stock results show that Axonics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace Performance YTD +13.41% +13.41% 1 Month +0.22% +0.22% 3 Month +1.32% +1.32% 6 Month -0.38% -0.38% 1 Year +25.04% +25.04% More News Read More Axonics Reports First Quarter 2024 Financial Results April 30, 2024 From Axonics, Inc. Via Business Wire Boston Scientific Bucks the Medtech Slow Down and Raises Outlook April 30, 2024 Via MarketBeat Beyond The Numbers: 7 Analysts Discuss Axonics Stock February 29, 2024 Via Benzinga Analyst Scoreboard: 5 Ratings For Axonics January 09, 2024 Via Benzinga Why Axonics Stock Soared Today January 08, 2024 Via The Motley Fool FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious' April 18, 2024 Via Benzinga Exposures Product Safety Axonics Stockholders Approve Merger Agreement with Boston Scientific March 22, 2024 From Axonics, Inc. Via Business Wire Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System March 14, 2024 From Axonics, Inc. Via Business Wire Axonics Responds to ITC Action by Medtronic February 29, 2024 From Axonics, Inc. Via Business Wire Health Care Company Boston Scientific Announces Acquisition of Axonics January 08, 2024 Via Benzinga Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results February 28, 2024 From Axonics, Inc. Via Business Wire AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX February 27, 2024 From Kahn Swick & Foti, LLC Via Business Wire Why Medical Devices Giant Boston Scientific Shares Are Rising Today January 31, 2024 Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP) January 16, 2024 From Brodsky & Smith LLC Via GlobeNewswire Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review January 12, 2024 Via Investor's Business Daily Topics ETFs Robinhood, Palo Alto Networks And 2 Other Stocks Insiders Are Selling January 11, 2024 Via Benzinga 10 Top Stocks With a Strong Buy Rating Right Now January 09, 2024 Via InvestorPlace BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP) January 08, 2024 From Brodsky & Smith LLC Via GlobeNewswire Why Is Crocs (CROX) Stock Up 20% Today? January 08, 2024 Via InvestorPlace Why Is Axonics (AXNX) Stock Up 20% Today? January 08, 2024 Via InvestorPlace Why Is Bladder Disorder Focused Axonics Stock Trading Higher Today? January 08, 2024 Via Benzinga Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 08, 2024 Via Benzinga J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value January 08, 2024 Via Investor's Business Daily Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.